1. Home
  2. KRYS vs EXLS Comparison

KRYS vs EXLS Comparison

Compare KRYS & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$279.47

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo ExlService Holdings Inc.

EXLS

ExlService Holdings Inc.

HOLD

Current Price

$40.53

Market Cap

6.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
EXLS
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.6B
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
KRYS
EXLS
Price
$279.47
$40.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
4
Target Price
$250.50
$53.00
AVG Volume (30 Days)
299.1K
1.0M
Earning Date
02-18-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
275.72
29.94
EPS
6.66
1.48
Revenue
$373,164,000.00
$2,026,490,000.00
Revenue This Year
$36.14
$15.32
Revenue Next Year
$42.38
$11.37
P/E Ratio
$41.84
$28.83
Revenue Growth
54.51
14.43
52 Week Low
$122.80
$37.30
52 Week High
$295.98
$52.43

Technical Indicators

Market Signals
Indicator
KRYS
EXLS
Relative Strength Index (RSI) 62.12 38.20
Support Level $275.00 $41.47
Resistance Level $294.64 $43.19
Average True Range (ATR) 11.68 0.87
MACD -0.51 -0.17
Stochastic Oscillator 68.67 7.37

Price Performance

Historical Comparison
KRYS
EXLS

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: